Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
PaperCitations, authors & open-access status
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 365 citations, 2008 year and green oa status.
365
Citations
2008
Year
green
OA Status